Sandvine Receives $5 Million in Expansion Orders from Tier 1 Operators in EMEA Canada NewsWire
WATERLOO, ON , July 15, 2014 /CNW/ - Sandvine (TSX: SVC) , a leading provider of intelligent broadband and network solutions for fixed and mobile operators, today announced that it has received more than $5 million of follow-on orders from two tier 1 service providers in its European Middle East and Africa sales region.
Sandvine reports Q2 2014 results Canada NewsWire
WATERLOO, ON , July 10, 2014 /CNW/ - Sandvine , (TSX:SVC) a leading provider of intelligent network policy control solutions for fixed and mobile operators, today reported revenue of $29.7 million for its second quarter of 2014, net income of $4.4 million and non-IFRS income of $4.8 million .
OLNEY, Md., July 31, 2014 (GLOBE NEWSWIRE) -- Sandy Spring Bancorp, Inc., (Nasdaq:SASR) , the parent company of Sandy Spring Bank, announced that the board of directors declared a quarterly common stock dividend of $0.20 per share payable on August 20, 2014 to shareholders of record on August 13, 2014.
OLNEY, Md., July 17, 2014 (GLOBE NEWSWIRE) -- Sandy Spring Bancorp, Inc., (Nasdaq:SASR) the parent company of Sandy Spring Bank, today reported net income for the second quarter of 2014 of $7.0 million ($0.28 per diluted share) compared to net income of $12.2 million ($0.49 per diluted share) for the second quarter of 2013 and net income of $10.9 million ($0.43 per diluted share) for the first quarter of 2014.
Control of Viral Load During Treatment Interruption of Antiretroviral Therapy Sustained and Ongoing for More than One Year in One Subject and Several Months in Another
Additional Presentation Demonstrates Potential Mechanisms for Unprecedented HIV Reservoir Depletion by SB-728-T RICHMOND, Calif.
Sign-up for Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-T investment picks
Together with Excellence Cluster Cardio-Pulmonary System (ECCPS) and
TransMIT Gesellschaft für Technologietransfer mbH (TransMIT), Sangui is
investigating new therapeutic approaches to treating septic shock and
acute respiratory distress syndrome (ARDS).
Owing to their incidence rate, complexity and poor prognosis, the two
diseases constitute a huge challenge in both in terms of their
socio-economic impact and the associated intensive medical care, and
incur unacceptably high mortality rates, despite progress made in
According to preliminary, unaudited figures Sangui Biotech
International, Inc. yielded revenues from royalties and product sales of
USD42,000 in the course of the fourth quarter of its financial year
2014, ended June 30, 2014.
Sankaty Advisors, LLC, the independently managed credit affiliate of
Bain Capital, today announced the signing of a definitive agreement to
acquire a portfolio of loans and other securities from J.P. Morgan’s
Global Special Opportunities Group.
NEW YORK (MarketWatch) -- Shares of Sanmina-SCI (SANM) ran up 8.3% in after-hours trade Monday after the electronics contract manufacturer reported better-than-expected fiscal third-quarter results and provided an upbeat outlook for the current quarter.
PARIS and MINNEAPOLIS, June 14, 2014 (GLOBE NEWSWIRE) -- Sanofi (EURONEXT:SAN) (NYSE:SNY) and Medtronic, Inc. (NYSE:MDT) today announced that they have signed a memorandum of understanding to enter into a global strategic alliance in diabetes, aimed at improving patient experience and outcomes for people with diabetes around the world.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.